2005

1. McNeill SA, Hargreave TB, Roehrborn CG; Alfaur study group. Alfuzosin 10 mg once daily in the management of acute urinary retention: Results of a double-blind placebo-controlled study. Urology 65(1): 83-89, 2005. (January)
2. Poon CI, Zimmern  PE , Wilson TS, Defreitas GA , Foreman MR: Three-dimensional ultrasonography to assess long-term durability of periurethral collagen in women with stress urinary incontinence due to intrinsic sphincter deficiency. Urology 65(1): 60-64, 2005. (January)
3. Pearle MS: Treatment of complete staghorn stones: a prospective randomized comparison of open surgery versus percutaneous nephrolithotomy. Int Braz J Urol 31(1):71-72, 2005. (Jan-Feb)
4. Pearle MS: Obesity, weight gain, and the risk of kidney stones. Int Braz J Urol 31(1): 70-71, 2005. (Jan-Feb)
5. Gupta A, Aragaki C, Gotoh M, Masumori N, Ohshima S, Tsukamoto T, Roehrborn CG: Relationship between prostate specific antigen and indexes of prostate volume in Japanese men. J. Urol. 173(2): 503-506, 2005. (February)
6. Wilson TS, Aziz KA, Vazquez D, Wuermser LA, Lin VK, Lemack GE: Changes in detrusor muscle myosin heavy chain mRNA expression following spinal cord injury in the mouse. Neurourol Urodyn. 24(1): 89-95, 2005.
7. Valentini FA, Griffiths DJ, Zimmern  PE , Besson GR, Nelson PP: Ann Readapt Med Phys. 48(1): 11-19, 2005 (French) (February)
8. Hornberger BJ, Elmore JM, Roehrborn CG: Idiopathic scrotal elephantiasis. Urology 65(2): 389, 2005. (February)
9. Pearle MS, Calhoun EA, Curhan GC: Urologic diseases in America  project: urolithiasis. J Urol 173(3): 848-857, 2005. (March)
10. Snodgrass WT: Snodgrass technique for hypospadias repair. BJU Int 95(4): 683-693, 2005. (March)
11. Godbole PP, Wilcox DT, Mushtaq I: Follow-up after unilateral nephrectomy in children: is an estimate of glomerular filtration rate necessary? BJU Int 95(4):635-637, 2005. (March)
12. Benaim EA: Editorial Comment. Urology 65(3): 503, 2005. (March)
13. Lotan Y, Cadeddu JA, Lee JJ, Roehrborn CG, Lippman SM: Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes. J Clin Oncol 23(9): 1911-1920. (March)
14. Johnson DB, Duchene DA, Taylor GD, Pearle MS, Cadeddu JA: Contrast-enhanced ultrasound evaluation of radiofrequency ablation of the kidney: reliable imagining of the thermolesion. J Endourol 19(2): 248-252, 2005. (March)
15. Pearle MS: Percutaneous nephrolithotomy for caliceal diverticular calculi: a novel single stage approach. Int Braz J. Urol 31(2): 162-163, 2005. (March – April)
16. Pearle MS: Emergency extracorporeal shockwave lithotripsy for acute renal colic caused by upper urinary tract stones. Int Braz J Urol 31 (2) 163-164, 2005. (March – April)
17. Yair Lotan and Jeffrey A. Cadeddu: Upper urinary tract: a cost comparison of nephron-sparing surgical techniques for renal tumour. BJU International 95: 1039-1042, 2005. (May)
18. Lin VK, Wang SY, Boetticher  NC  , Vazquez DV, Saboorian H, McConnell JD, Roehrborn CG: Alpha (2) macroglobulin, a PSA binding protein, is expressed in human prostate stroma.  Prostate 63(3): 299-308, 2005. (May)
19. Shariat SF, Zippe C, Ludecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C, Friedrich MG, Eissa S, Akaza H, Sawczuk I, Serretta V, Huland H, Hedelin H, Rupesh R, Miyanaga N, Sagalowsky AI, Wians F Jr., Roehrborn CG, Lotan Y, Perrotte P, Benayoun S, Marberger MJ, Karakiewicz PI: Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with ta, t1 or cis transitional cell carcinoma of the bladder. J. Urol. 173(5): 1518-1525, 2005. (May)
20. Gundeti MS, Ransley PG, Duffy PG, Cuckow PM, Wilcox DT: Renal outcome following heminephrectomy for duplex kidney. J. Urol. 173 (5): 1743-1744, 2005. (May)
21. Eggener SE, Lotan Y, Cheng EY: Magnetic resonance angiography for the nonpalpable testis: A cost and cancer risk analysis. J. Urol. 173(5): 1745-1750, 2005. (May)
22. Malaeb BS, Martin DJ, Littooy FN, Lotan Y, Waters WB, Flanigan RC, Koeneman  KS : The utility of screening renal ultrasonography: identifying renal cell carcinoma in an elderly asymptomatic population. BJU Int. 95(7): 977-981, 2005 (May)
23. Gary E. Lemack, Kathleen Hawker, and Elliot Frohman: Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis: analysis of risk factors at initial urologic evaluation. Urology 65: 854-857, 2005. (May)
24. Edward D. Matsumoto, D. Brooke Johnson, Kenneth Ogan, Clayton Trimmer, Arthur Sagalowsky, Vitaly Margulis, and Jeffrey Cadeddu: Short-Term efficacy of temperature-based radiofrequency ablation of small renal tumors. Urology 65: 877-881, 2005. (May)
25. Pearle MS:   Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. Int Braz J. Urol 31(3): 271, 2005 (May – June)
26. Pearle MS:      Is newer always better? A comparative study of 3 lithotriptor generations. Int Braz J. Urol 31(3): 271-272, 2005. (May-June)
27. Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS Jr.; AUA Nephrolithiasis Guidleline Panel: Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J. Urol. 173(6): 1991-2000, 2005. (June)
28. Pearle MS, Lingeman JE, Leveillee R, Kuo R, Preminger GM, Nadler RB, Macaluso J, Monga M, Kumar U, Dushinski J, Albala DM, Wolf JS Jr., Assimos D, Fabrizio M, Munch LC, Nakada SY, Auge B, Honey J, Ogan K, Pattaras J, McDougall EM, Averch TD, Turk T, Pietrow P, Watkins S: Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J. Urol. 173(6): 2005-2009, 2005 (June)
29. Gordon SA, Stage KH, Tansey KE, Lotan Y: Conservative management of priapism in acute spinal cord injury. Urol., 65(6): 1195-1197, 2005. (June)
30. Shulman MJ, Benaim EA: Prognostic model of event-free survival for patients with androgen-independent prostate carcinoma. Cancer 103(11): 2280-2286, 2005 (June)
31. Lotan Y, Cadeddu JA, Pearle MS: International comparison of cost effectiveness of medical management strategies for nephrolithiasis. Urol Res 33(3) 223-30, 2005. (June 2005)
32. Vitaly Margulis, Edward D. Matsomoto, Grant Taylor, Stephanie Shaffer, Wareef Kabbani and Jeffrey A. Cadeddu: Retrograde renal cooling during radio frequency ablation to protect from renal collecting system injury. J. Urol., 174: 350-352, 2005. (July)
33. Robert S. Svatek, David Lee, and Yair Lotan: Correlation of office-based cystoscopy and cytology with histologic diagnosis: how good is the reference standard? Urology, 66: 65-68, 2005. (July)
34. Pearle MS: Shock wave lithotripsy at 60 or 120 shocks per minute: a randomized, double-blind trial. Int Braz J Urol. 31(4): 391-392, 2005 (July-August)
35. Pearle MS: Randomized controlled study of mechanical percussion, diuresis, and inversion therapy to assist passage of lower pole renal calculi after shock wave lithotripsy. Int Braz J Urol. 31(4): 392-393, 2005 (July-August)
36. Sozubir S, Ewalt D, Strand W, Baker LA: Familial ureteroceles: an evidence for genetic background? Turk J Pediatr 47(3): 255-260, 2005 (July-September)
37. Gettman  , MT , Ogan K, Brinkley LJ, Adams-Huet B, Pak CY, Pearle MS: Effect of cranberry juice consumption of urinary stone risk factors. J. Urol., 174(2): 590-594; quiz 801, 2005 (August)
38. Magulis V. Matsumoto ED, Svatek R, Kabbani W, Cadeddu JA, Lotan Y: Application of novel hemostatic agent during laparoscopic partial nephrectomy. J. Urol. 174(2): 761-764, 2005. (August)
39. Snodgrass WT: The island tube and island onlay hypospadias repairs offer excellent long-term outcomes: a 14-year followup. J. Urol 174(2): 792-793, author reply 793, 2005 (August)
40. Lemack GE: How many patients are required to achieve statistically significant results? Curr Urol Rep 6(5): 363, 2005 (September)
41. Lemack GE: A prospective subjective and objective outcome analysis of tension-free vaginal tape. Curr Urol Rep 6(5): 363-364, 2005 (September)
42. Shariat SF, Hetman MP, Casella R, Lotan Y, Karam JA, Stenman UH: Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder. Eur Urol. 48(3): 424-431, 2005 (September)
43. Roehrborn CG, Lukkarinen O, Mark S, Siami P, Ramsdell J, Zinner N: Long-term sustained improvement in symptoms of benign prostatic hyperplasia with the dual 5alpha-reductase inhibitor dutasteride: results of 4-year studies. BJU Int. 96(4): 572-577, 2005 (September).
44. Roehrborn CG, Prajsner A, Kirby R, Andersen M, Quinn S, Mallen S: A double-blind placebo-controlled study evaluating the onset of action of doxazosin gastrointestinal therapeutic system in the treatment of benign prostatic hyperplasia. Eur Urol. 48(3): 445-52, 2005 (September)
45. Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI: Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23(27): 6533-6539, 2005 (September)
46. Snodgrass WT: Assessing outcomes of hypospadias surgery. J Urol. 174(3): 816-817, 2005 (September).
47. J. Kyle Anderson, Adam Murdock, Jeffrey A. Cadeddu, and Yair Lotan: Cost comparison of laparoscopic versus radical retropubic prostatectomy. Urology 66: 557-560, 2005 (September)
48. Anderson JK, Matsumoto E, Cadeddu JA: Renal radofrequency ablation: Technique and results. Urol Oncol. 23(5): 355-360, 2005 (September – October)
49. Pearle MS: Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones.   Int Braz J Urol. 31(5):492-493, 2005 (September-October)
50. Pearle MS: Effect of urethral access sheath on stone-free rates in patients undergoing ureteroscopic management of renal calculi. Int Braz J Urol. 31(5): 493-494, 2005 (September- October)
51. Vitaly Margulis, Edward D. Matsumoto, Lutfi Tunc, Grant Taylor, David Duchenne and Jeffrey A. Cadeddu: Effect of warmed, humidified insufflation gas and anti-inflammatory agents on cytokine response to laparoscopic nephrectomy: Porcine model. J. Urology 174:1452-1456, 2005 (October).
52. Seth A. Alpert, Earl Y. Cheng, William E. Kaplan, Warren T. Snodgrass, Duncan T. Wilcox and Bradley P. Kropp: Bladder neck fistula after the complete primary repair of exstrophy: A multi-institutional experience. J. Urology 174: 1687-1690, 2005 (October)
53. Sharokh F. Shariat, Raheela Ashfaq, Claus G. Roehrborn, Kevin M. Slawin, and Yair Lotan: Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia. J. Urology 174: 2046-2050, 2005 (November)
54. Pak CY, Odvina CV, Pearle MS, Sakhaee K, Peterson RD  , Poindexter JR, Brinkley LJ: Effect of dietary modification on urinary stone risk factors. Kidney Int 68(5): 2264-2273, 2005 (November)
55. Taghizadeh  AK , Wilcox DT: A posterior sagittal approach for revision vaginoplasty. BJU Int 96(7): 1115-1117, 2005 (November)
56. Matsumoto ED, Margulis V, Tunc L, Taylor GD, Duchene D, Johnson DB, Pearle MS, Cadeddu JA: Cytokine response to surgical stress: comparison of pure laparoscopic, hand-assisted laparoscopic, and open nephrectomy. J. Endourology 19(9): 1140-1145, 2005 (November)
57. Sarosdy MF, Tangen CM, Weiss GR, Nestok BR, Benson MC, Schellhammer PF, Sagalowsky AI, Wood DP Jr., Crawford ED: A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guerin for carcinoma in situ of the bladder: A Southwest Oncology Group Study. Urol. Oncol. 23(6): 386-389, 2005 (November)
58. Gerald Andriole, David Bostwick, Francisco Civantos, Jonathan Epstein, M. Scott Lucia, John McConnell and Claus G. Roehrborn: The effects of 5"-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge. J. Urology 174: 2098-2104, 2005 (December)
59. Recart A, Duchene D, White PF, Thomas T, Johnson DB, Cadeddu JA: Efficacy and safety of fast-track recovery strategy for patients undergoing laparoscopic nephrectomy. J Endourol 19(10): 1165-1169, 2005 (December)
60. Shariat SF, Duchene D, Kabbani W, Mucher Z, Lotan Y: Gastrointestinal hemorrhage as first manifestation of metastatic testicular tumor. Urology 66(6): 1319, 2005 (December)

Return to Basic Science Research

For more information about the Department of Urology, contact:

Phone: 214-648-4765, FAX: 214-648-4789

Mailing Address: 5323 Harry Hines Blvd. , J8.148, Dallas , TX 75390-9110